Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.
about
Cobalamin deficiency, hyperhomocysteinemia, and dementiaObesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature ReviewClinical Relevance of Biomarkers of Oxidative StressBlood markers of oxidative stress in Alzheimer's diseaseRedox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's diseaseEffects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detectionLipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesTriangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedEffects of APOE rs429358, rs7412 and GSTM1/GSTT1 Polymorphism on Plasma and Erythrocyte Antioxidant Parameters and Cognition in Old Chinese Adults.Oxidative and nitrative stress in neurodegeneration.Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons.Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo.Redox Proteomic Profiling of Specifically Carbonylated Proteins in the Serum of Triple Transgenic Alzheimer's Disease Mice.Association of Biomarkers for Inflammation, Endothelial Dysfunction and Oxidative Stress with Cognitive Impairment. The Epidemiology of Hearing Loss Study (EHLS).The thiol pool in human plasma: the central contribution of albumin to redox processes.The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.Dietary lipids and their oxidized products in Alzheimer's disease.Elevation of glutathione as a therapeutic strategy in Alzheimer disease.The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Associations between Specific Redox Biomarkers and Age in a Large European Cohort: The MARK-AGE Project.GRP78 at the Centre of the Stage in Cancer and Neuroprotection.Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.Cilostazol prevents amyloid β peptide(25-35)-induced memory impairment and oxidative stress in mice.Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia.Effects of inactivity on human muscle glutathione synthesis by a double-tracer and single-biopsy approach.Lycium barbarum polysaccharide protects against neurotoxicity via the Nrf2-HO-1 pathway.2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis.End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease.Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels.Oxidative imbalance in different neurodegenerative diseases with memory impairment.Effect of Cinnamomum zeylanicum extract on scopolamine-induced cognitive impairment and oxidative stress in rats.The neuroprotective role of melatonin in neurological disorders.Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.Beneficial Effects of Elderly Tailored Mediterranean Diet on the Proteasomal Proteolysis.Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease.The Effects of Fermented Laminaria japonica on Short-Term Working Memory and Physical Fitness in the Elderly.
P2860
Q24609123-5E13549E-BA24-4745-BAF9-902C4A27EE80Q26771735-D05D0A32-518A-4017-9E99-1336DDFE8A50Q26785512-1057A336-CA5F-493F-A16D-85BC153D745BQ27021625-F780E90D-8E2B-4D51-9A68-B322E86E2AB6Q33494148-238D5CC9-2D33-4D68-80FB-9425E9F3AA90Q33767975-BAE78EDF-E3B2-4541-AA7E-AD2BB78C4FD7Q33787909-2038C48B-C8A2-4EB0-9077-34D3A0841807Q34288447-94195CFA-F6E3-458B-972F-9D68FC40C1EBQ35997884-59948EBE-D3F3-4D29-BA81-12CF8C0396D6Q36246699-08408DC3-B698-41CB-91C4-03EABA465DFEQ36326881-458CD61B-21E0-4295-A65A-9E238ACA0715Q36420162-7734B260-9E29-4B67-BECD-69FDFDB752D3Q36744769-678AB525-85D4-46CF-98E2-98844914588EQ36797863-EDFCC98E-0E54-4693-9F0D-5E1A30680127Q36846943-86DE36B9-E444-4692-A7C2-2EC839BE736AQ36956612-83471505-03D5-4282-A298-28B7402343EAQ37540768-4908BEF0-1092-40DC-A550-D1B1B129C758Q37575502-D8C039D3-04DC-496C-9525-AE991EB0BDA0Q37616153-C326E7DF-5E11-4D5F-A8FE-D8E93CA76A09Q37910243-13EF5088-436C-4611-8C13-CF4F07FE7F4CQ37939806-166C679E-108C-4B41-A43E-18A1CB7D9977Q37947939-D77DD42D-36B4-478E-B69A-CF042B6E5CF0Q38004705-FC89C2BE-7396-4879-B9C9-8769321E95CFQ38626604-48913309-A403-46B6-A11C-C1775AEFA496Q38692967-0B70DEE2-8650-43B9-89ED-CA8EBFF69D78Q40097111-8E7E042F-453D-4809-A5A8-1B88A812D0E7Q41485665-91D50BDD-7D31-4220-9DB2-4F8B25D99811Q41986372-42622C2D-9205-467C-B277-3588217A52C6Q42852605-7975448C-814B-43BF-AE6B-7164F7491AC2Q46248810-869347BF-4EFF-4A43-96A2-8B2ECBF9F70BQ46309260-A9D18A4F-1340-4F8F-8AA6-B24BFC01A981Q48786204-4A2993B0-DA97-4E69-B787-82D99AEAC0ABQ48807073-EFF287A2-2C6E-4C07-8375-878CC158B984Q49043217-E335C79F-82CD-46E1-93BC-CCC6155643D5Q50686924-EDFA1A1C-F63C-4E72-A3D0-CF0FD9AB22A4Q53396094-1D581D6D-588D-442D-A004-F768B94F1776Q55281774-DBC2484F-4156-49EA-9B61-AEAEF143828FQ55356592-28798E02-36F7-4B90-B68F-C84E6C6B0D82Q55514851-E4A48924-903F-4528-ACF1-B32BA88AD024Q55638368-57627038-F231-4A21-95C6-2532E80509E4
P2860
Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@en
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@nl
type
label
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@en
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@nl
prefLabel
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@en
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@nl
P2093
P2860
P1476
Malondialdehyde, carbonyl prot ...... rment and Alzheimer's disease.
@en
P2093
F Leblhuber
J Greilberger
K Schroecksnadel
M Greilberger
M Lamprecht
P2860
P304
P356
10.1080/10715760802255764
P577
2008-07-01T00:00:00Z